With origins in the 1950s, Carter BloodCare is one of Texas' largest blood centers, providing 300,000 units of life-saving blood and blood components to patients in North, Central, and East Texas annually.
by Pamela L. Malvern, BSN, RN, CNN and Victoria Hall, BSN, RN Sickle cell disease is the most common indication when red cell exchange is carried out by Carter BloodCare clinical apheresis staff. The procedure can be elective for those sickle cell disease patients whose clinical circumstances are best managed by performing exchange every six to…Read More
by William Crews, MD Cryoprecipitated Antihemophilic Factor is more commonly known as cryoprecipitate, or simply cryo. Cryoprecipitate can only be made from Fresh Frozen Plasma (FFP), which has been removed from whole blood and frozen within eight hours of being collected. The FFP is slowly thawed between 1 and 6C. This results in a supernatant that…Read More
by Laurie J. Sutor, MD, MBA, VP of Medical and Technical Services Irradiation of blood is done to prevent graft-versus-host disease (GVHD) in susceptible patients getting transfusion. Current practice in U.S. blood banks tends to use one of two types of dedicated blood component irradiators: the traditional cesium source irradiator which emits gamma rays, or…Read More
Katherine Kay Blevens chooses to celebrate the purest joys in her life – husband, children and grandchildren, despite being diagnosed with sickle cell disease as a baby. When she was a teenager, she was told that she would not live past 21. The reason why sickle cell disease carries such a grim prognosis is because…Read More
Carter BloodCare's Cellular Therapy Laboratory has been entrusted to assist with the initial collection, cryopreservation, preparation for patient infusion and administration of stem cell products. This video takes a behind-the-scenes look at the process. [embed]https://youtu.be/38seNmzKOiU[/embed]Read More